Zimmer Holdings Inc (ZMH)

ZMH on New York Consolidated

118.57USD
30 Mar 2015
Change (% chg)

$1.07 (+0.91%)
Prev Close
$117.50
Open
$118.06
Day's High
$118.99
Day's Low
$117.77
Volume
723,078
Avg. Vol
1,210,622
52-wk High
$121.84
52-wk Low
$90.48

ZMH

Chart for ZMH

About

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The Company also provides other healthcare related services. The Company’s customers include orthopaedic surgeons, neurosurgeons, oral... (more)

Overall

Beta: 0.92
Market Cap(Mil.): $19,975.65
Shares Outstanding(Mil.): 170.01
Dividend: 0.22
Yield (%): 0.75

Financials

  ZMH Industry Sector
P/E (TTM): 28.01 41.23 40.78
EPS (TTM): 4.19 -- --
ROI: 8.39 10.80 16.19
ROE: 11.24 12.60 17.04
Search Stocks

EU mergers and takeovers (March 30)

BRUSSELS, March 30 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

10:34am EDT

Zimmer wins EU approval for $13.4 billion Biomet acquisition

BRUSSELS - U.S. medical device maker Zimmer gained European Union regulatory approval on Monday for its proposed $13.4 billion purchase of rival Biomet [LVBHAB.UL] after agreeing to divest three businesses in Europe to allay competition concerns.

5:55am EDT

Zimmer wins EU approval for $13.4 bln Biomet acquisition

BRUSSELS, March 30 - U.S. medical device maker Zimmer gained European Union regulatory approval on Monday for its proposed $13.4 billion purchase of rival Biomet after agreeing to divest three businesses in Europe to allay competition concerns.

5:50am EDT

Deals of the day-Mergers and acquisitions

March 18 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

18 Mar 2015

EU to clear Zimmer's $13.4 billion Biomet deal: sources

BRUSSELS - U.S. medical device maker Zimmer is set to secure conditional approval from European Union regulators for its proposed $13.4 billion takeover of rival Biomet [LVBHAB.UL], two people with knowledge of the matter said on Wednesday.

18 Mar 2015

UPDATE 1-EU to clear Zimmer's $13.4 bln Biomet deal -sources

BRUSSELS, March 18 - U.S. medical device maker Zimmer is set to secure conditional approval from European Union regulators for its proposed $13.4 billion takeover of rival Biomet, two people with knowledge of the matter said on Wednesday.

18 Mar 2015

EU regulators set new May 26 deadline for Zimmer's Biomet deal

BRUSSELS, Feb 10 - European Union antitrust regulators will decide by May 26 whether to approve U.S. medical device maker Zimmer's $13.4 billion bid for rival Biomet after Zimmer modified concessions to allay competition concerns.

10 Feb 2015

Stryker CEO says he remains focused on acquisitions

- The chief executive officer of U.S. medical device maker Stryker Corp , recently rumored to have been preparing a bid for British rival Smith & Nephew Plc , said on Tuesday that acquisitions are his top priority for spending cash, but he gave no hint that any sort of deal was imminent.

27 Jan 2015

Stryker CEO says he remains focused on acquisitions

Jan 27 - The chief executive officer of U.S. medical device maker Stryker Corp, recently rumored to have been preparing a bid for British rival Smith & Nephew Plc , said on Tuesday that acquisitions are his top priority for spending cash, but he gave no hint that any sort of deal was imminent.

27 Jan 2015

U.S. appeals court cuts damages Zimmer must pay Stryker

- A U.S. federal appeals court has slashed the damages that Zimmer Holdings Inc will have to pay Stryker Corp for infringing its patents on a surgical cleaning wand.

19 Dec 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks